| Question 9.1 |
| Question 28 |
| Question 18 | Regional citrate for CRRT: basically everything about it |
| Question 8 |
| Question 28 | |
| Question 20.1 | |
| Question 13 | |
| Question 4.2 | Causes of rhabdomyolysis |
| Question 5.2 | Citrate toxicity: how will you change the dialysis prescription? |
| Question 1 | Rhabdomyolysis: causes, features, investigations and management |
| Question 29 |
| Question 7 |
| Question 15 | |
| Question 9.3 | Causes of renal failure: reabsorption of excreted wastes in bladder rupture |
| Question 26 | CVVHDF circuit diagram and troubleshooting of the dialysis circuit |
| Question 21 | |
| Question 19.2 | |
| Question 19.1 | Troubleshooting the dialysis circuit (haemolysis, causes of red effluent) |
| Question 19 |
| Question 5 | Rhabdomyolysis following head and neck surgery |
| Question 15 | Renal failure: protection from contrast, antibiotic dosing, indications for dialysis |
| Question 13.3 | Causes of renal failure: interstitial nephritis due to β-lactams |
| Question 29 |
| Question 21 | A comparison of renal replacement therapy modalities: CVVHF vs SLED vs IHD |
| Question 22 | Citrate anticoagulation of the CRRT circuit and citrate toxicity. |
| Question 30 | Definitions of CRRT terminology; also the CVVHDF circuit diagram |
| Question 22 | Plasmapheresis: principles of use, indications and complications. |
| Question 29 |
| Question 29 |
| Question 6.3 | Random uraemia: list of differentials for an electrolyte panel, with zero history. |
| Question 6.2 | Rhabdomyolysis following AAA repair |
| Question 12 | A critique of the RIFLE classification system. |
| Question 16 | Indications for dialysis in the ICU; strategies to optimise solute clearance. |
| Question 10 | A comparison of renal replacement therapy modalities: CVVHD vs SCUF vs IHD |
| Question 1 |
| Question 4 |
| Question 14 | Plasmapheresis: principles, indications, complications. |
| Question 12 | Rhabdomyolysis, optimising solute clearance, troubleshooting CRRT, and dose of CRRT. |
| Question 2 | Biomarkers in assessment of acute kidney injury, eg urea:creatinine ratio |
| Question 12 | |
| Question 5.4 | |
| Question 5.3 | Troubleshooting the dialysis circuit (blood leak into the effluent) |
| Question 5.2 | Troubleshooting the dialysis circuit (very negative access pressure alarm) |
| Question 5.1 | Pre-dilution and post-dilution replacement fluid: advantages of pre-dilution. |
| Question 19 | A comparison of renal replacement therapy modalities: CVVHF vs SLED vs IHD. |
| Question 16 | |
| Question 11 | Causes of renal failure; also the approach to the assessment of oligoanuria |
| Question 6.2 | Random uraemia: list of differentials for an electrolyte panel, with zero history. |
| Question 25 | A comparison of biochemical indices in diagnosis of pre-renal failure. |
| Question 14 |
| Question 24 | Causes of renal failure; also rhabdomyolysis as a cause of acute kidney injury |
| Question 17 | Strategies to prolong the lifespan of the CRRT circuit - citrate anticoagulation |
| Question 8 |
| Question 29 | Prevention of acute renal failure (contrast-induced nephropathy) in AAA repair. |
| Question 5 | Plasmapheresis: indications, advantages, disadvantages. "Critically evaluate". |
| Question 14 | |
| Question 4 |
| Question 6 |
| Question 5 |
| Question 1 |